Palliative benefit of novel cell-free and concentrated ascites reinfusion therapy (CART) for refractory ascites associated with cancerous peritonitis.

被引：0
|
作者：
Matsusaki, Keisuke
Yoshizawa, Akitaka
Ohta, Kelichiro
机构：
[1] Kanarnecho Hosp, Ascites Treatment Ctr, Tokyo, Japan
[2] Shonan Karnakura Gen Hosp, Ctr Canc, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20591
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cell-Free and Concentrated Ascites Reinfusion Therapy Is More Effective for Refractory Ascites in Patients with Autosomal Dominant Polycystic Kidney Disease
    Kurihara, Shigekazu
    Suwabe, Tatsuya
    Yamanouchi, Masayuki
    Ubara, Yoshifumi
    Kamijo, Yuji
    Sawa, Naoki
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [32] Cell-free and concentrated ascites reinfusion therapy for refractory massive cardiac ascites in an adult with single ventricle haemodynamics: a case report
    Tsukishiro, Yasue
    Yamamoto, Hiroyuki
    Masumoto, Akiko
    Takaya, Tomofumi
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2023, 7 (03)
  • [33] Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer
    Maeda, Osamu
    Ando, Takafumi
    Ishiguro, Kazuhiro
    Watanabe, Osamu
    Miyahara, Ryoji
    Nakamura, Masanao
    Funasaka, Kohei
    Kazuhiro, Furukawa
    Ando, Yuichi
    Goto, Hidemi
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 1103 - 1106
  • [34] Occurrence of fever in cell-free and concentrated ascites reinfusion therapy is not related to the primary disease or nature of ascites
    Fukunaga, Shohei
    Egawa, Masahiro
    Ito, Takafumi
    Tanabe, Kazuaki
    JOURNAL OF ARTIFICIAL ORGANS, 2024, 27 (02) : 138 - 145
  • [35] Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study
    Ishitani, Ken
    Isoai, Ayako
    Ito, Tetsuya
    Sugiyama, Hiroshi
    Arakawa, Atsushi
    Yamada, Yosuke
    Onodera, Hirokazu
    Kobayashi, Ryosuke
    Torii, Naoko
    Soneda, Noriko
    Matsuno, Yoshihiro
    Utsugisawa, Taiju
    Kato, Michio
    Hanafusa, Norio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (06) : 1130 - 1138
  • [36] Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study
    Ken Ishitani
    Ayako Isoai
    Tetsuya Ito
    Hiroshi Sugiyama
    Atsushi Arakawa
    Yosuke Yamada
    Hirokazu Onodera
    Ryosuke Kobayashi
    Naoko Torii
    Noriko Soneda
    Yoshihiro Matsuno
    Taiju Utsugisawa
    Michio Kato
    Norio Hanafusa
    International Journal of Clinical Oncology, 2021, 26 : 1130 - 1138
  • [37] Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
    Yokomichi, Naosuke
    Imai, Kengo
    Sakamoto, Masaki
    Horiki, Masashi
    Yamauchi, Toshihiro
    Miwa, Satoru
    Inoue, Satoshi
    Uneno, Yu
    Suzuki, Hidekazu
    Wada, Toru
    Ichikawa, Yuri
    Morita, Tatsuya
    BMC CANCER, 2022, 22 (01)
  • [38] Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
    Naosuke Yokomichi
    Kengo Imai
    Masaki Sakamoto
    Masashi Horiki
    Toshihiro Yamauchi
    Satoru Miwa
    Satoshi Inoue
    Yu Uneno
    Hidekazu Suzuki
    Toru Wada
    Yuri Ichikawa
    Tatsuya Morita
    BMC Cancer, 22
  • [39] Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites
    Ito, Tetsuya
    Hanafusa, Norio
    Soneda, Noriko
    Isoai, Ayako
    Kobayashi, Ryosuke
    Torii, Naoko
    Kato, Michio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (11) : 3224 - 3232
  • [40] Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
    Tsubokura, Misato
    Adegawa, Yuko
    Kojima, Minoru
    Tanosaki, Ryuji
    Ohtake, Ryuzaburo
    Kase, Yuki
    Iwashita, Nao
    Kasane, Moemi
    Nakabayashi, Saori
    Takeuchi, Sayaka
    Kato, Ken
    Boku, Narikazu
    Kanemitsu, Yukihide
    Okusaka, Takuji
    Fujimoto, Hiroyuki
    Yonemori, Kan
    Ishiki, Hiroto
    Kawamura, Kimihiko
    Satomi, Eriko
    Matsushita, Hiromichi
    BMC CANCER, 2022, 22 (01)
12345